Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Shirish Gadgeel

Dr. Shirish Gadgeel

Medical Oncologist

Dr. Shirish Gadgeel is a medical oncologist at the Henry Ford Cancer Institute in Detroit, where he serves as associate director of patient experience and clinical care.

Get in touch
Jump to a Topic:

About Shirish Gadgeel

  • Pleural and Lung Cancer icon

    Pleural and Lung Cancer

  • Research Excellence icon

    Excellence in Research

  • Team Leader icon

    Team Leader

  • Board Certified icon

    Board Certified in Medical Oncology

  • Board Certified icon

    Board Certified in Internal Medicine

Get to Know Dr. Shirish Gadgeel

Medical oncologist Dr. Shirish Gadgeel is a lung cancer specialist who joined the Henry Ford Cancer Institute in 2020, bringing with him more than 20 years of experience in clinical research.

Gadgeel treats a variety of thoracic malignancies, including pleural mesothelioma, the rare and aggressive disease typically caused by long-ago exposure to asbestos.

He has played an instrumental role in numerous multicenter clinical trials that have advanced treatments in recent years through the development of novel immunotherapy, including the use of the drug pembrolizumab (Keytruda).

Gadgeel is a big believer in personalized medicine and multidisciplinary care. Throughout his career, he has been involved in several mesothelioma research projects, including one with specialist Dr. Harvey Pass of New York University.

During his tenure at nearby Karmanos Cancer Institute, Gadgeel’s team of oncologists developed new screening and detection tests for mesothelioma and finished a clinical study of novel mesothelioma therapeutics.

Before joining Henry Ford, he spent three years at University of Michigan Medicine and the Rogel Cancer Center, where he served as a research professor in thoracic oncology.

Specialties of Dr. Shirish Gadgeel

  • Lung cancer

  • Pleural mesothelioma

  • Clinical trials

  • Hematology

  • Thoracic malignancies

Dr. Shirish Gadgeel’s Experience and Medical Education

  • Henry Ford Cancer Institute

  • University of Michigan Medicine Rogel Cancer Center

  • Karmanos Cancer Institute

  • Wayne State University (Fellowship and residency)

Awards and Other Recognitions

  • Lung Cancer Committee of Southwest Oncology Group

  • Clinical Lung Cancer associate editor

  • National Cancer Institute, Cancer Clinical Investigator Team Leadership Award

  • American Society of Clinical Oncology, communications committee

  • Journal of Clinical Oncology, reviewer

Publications of Dr. Shirish Gadgeel

  • Sankar, K., Gadgeel, S.M. & Qin, A. (2020, July 7). Molecular therapeutic targets in non-small cell lung cancer. Expert Review of Anticancer Therapy.

  • Kumar, S. et al. (2020, July). Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic. Journal of Thoracic Oncology

  • Watza, D. et al. (2019, December 12). COPD-dependent effects of genetic variation in key inflammation pathway genes on lung cancer risk. International Journal of Cancer

  • Shaw, A. et al. (2019, June 1). ALK Resistance Mutations and Efficacy of Lorlatinib in Advanced Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer. Clinical Trial.

Disclaimer: Dr. Shirish Gadgeel has no professional affiliation with

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer. Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Henry Ford Health System. (n.d.). Shirish M. Gadgeel, MD. Retrieved from:

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified September 17, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now